1999
DOI: 10.1046/j.1365-4362.1999.00011.x
|View full text |Cite
|
Sign up to set email alerts
|

The use of intermittent itraconazole therapy for superficial mycotic infections: a review and update on the ‘one week’ approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2000
2000
2018
2018

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 110 publications
0
4
0
Order By: Relevance
“…Itraconazole is effective at a dosage of 200 mg/d, 190 when taken for either 5 or 7 days. The minimum cumulative dose for itraconazole is 1000 mg, although an improved efficacy is more likely to occur with the regimen of 200 mg/d for 7 days 196 Table 2. summarizes the randomized clinical trials that have been conducted using itraconazole to treat pityriasis versicolor 197–211 …”
Section: Treatmentmentioning
confidence: 99%
“…Itraconazole is effective at a dosage of 200 mg/d, 190 when taken for either 5 or 7 days. The minimum cumulative dose for itraconazole is 1000 mg, although an improved efficacy is more likely to occur with the regimen of 200 mg/d for 7 days 196 Table 2. summarizes the randomized clinical trials that have been conducted using itraconazole to treat pityriasis versicolor 197–211 …”
Section: Treatmentmentioning
confidence: 99%
“…Current concepts suggest that clinical trigger factors of rosacea such as ultraviolet (UV) radiation, heat, cold, psychological stress, spicy food, skin irritants, microbes (Demodex folliculorum) and others modulate TLR signalling, induce ROS and enhance antimicrobial peptide and neuropeptide production (20)(21)(22)(23)(24)(25). At the molecular level, all clinical rosacea triggers may represent ER stressors:…”
Section: Rosacea Trigger Factors Induce Er Stressmentioning
confidence: 99%
“…It is characterized by flushing/transient erythema, persistent erythema, papules, pustules and telangiectasia. [1,2] Characteristic vascular changes in rosacea skin include enlarged, dilated vessels of the upper dermis and blood flow increase. [3][4][5] Although the pathophysiology of rosacea is yet not fully understood, it is suggested that neurovascular overstimulation may contribute to the transient erythema and flushing.…”
Section: Introductionmentioning
confidence: 99%
“…[5,[7][8][9] The resulting chronic vasodilation and angiogenesis might ultimately progress to fixed changes in the vasculature, leading to persistent erythema. [1,5,10] Vascular remodelling is also a hallmark of many inflammatory diseases associated with hyperpermeability and changes in adhesion molecules. [11] In addition to vascular and neuroimmune dysregulation, innate and adaptive immune systems may also be involved in the development of rosacea.…”
Section: Introductionmentioning
confidence: 99%